Percutaneous Needle Tenotomy (PNT) Versus Platelet Rich Plasma (PRP) With PNT in the Treatment of Chronic Tendinosis

Not Applicable

Completed

• Conditions: Chronic Tendinopathy
• Interventions: Procedure: PNT + PRP; Procedure: PNT alone

• Registration Number: NCT01833598
• Lead Sponsor: Hospital for Special Surgery, New York

Brief Summary

Tendinopathy is a clinical syndrome of chronic pain and tendon degeneration that impairs a person's ability to perform daily activities and recreation. Traditional conservative treatments include activity modification, exercises, ice/heat, and medications and corticosteroid injection. A newer treatment is percutaneous needle tenotomy (PNT), in which the affected area is repetitively needled to disrupt pathological tissue and induce bleeding. This turns a nonhealing chronic injury into an acute injury with enhanced healing capability. Another is Platelet Rich Plasma (PRP), whereby patients' own platelets are injected into the affected area, also activating growth factors. There has been promising research in these tendinopathy treatments but more research is needed.

The investigators plan to expand on prior studies to identify a reproducible and efficacious treatment for chronic tendinopathy to reduce pain and improve function and quality of life. Our goal in this study is to assess the efficacy of ultrasound guided (USG) PNT versus PNT with peritendinous PRP as a treatment for chronic tendinopathy.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-09
• Study First Submitted: 2013-04-12
• Study First Submitted QC: 2013-04-16
• Study First Posted: 2013-04-17
• Primary Completion: 2019-06
• Study Completion: 2019-06
• Status Verified: 2020-11
• Last Update Submitted: 2020-12-22
• Last Update Posted: 2020-12-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• aged 18-100 years
• pain (≥ 5/10 pain on the VAS) that is a direct result of tendinosis as determined by history of injury and study team member physician's best judgment and review of medical records, imaging studies, etc.
• Tendinosis will be confirmed by clinical and ultrasonographic examination by the PI
• ≥3 months of pain after injury that has failed conservative treatments or after corticosteroid (CSI) (must be 3 months after CSI to avoid theoretical tendon rupture)

Exclusion Criteria

• taking coumadin or other anti-coagulant or anti-platelet medication

• known coagulopathy or bleeding dyscrasia

• current or recent fluoroquinolone prescription

• prior PNT or PRP for the affected tendon(s)

• known systemic illness such as vasculitis, an autoimmune or an inflammatory disease, or uncontrolled diabetes

• presence of other musculoskeletal injury or tendon rupture in the region

• currently are or plan to become pregnant during the study.

  • Patients taking aspirin or NSAIDs are not excluded.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
PNT + PRP	PNT + PRP	percutaneous needle tenotomy with peritendinous platelet-rich plasma injection
PNT alone	PNT alone	percutaneous needle tenotomy alone

Primary Outcome Measures

Name	Time	Method
Improvement in pain based on a visual analog score	Week 12

Secondary Outcome Measures

Name	Time	Method
Complications	Weeks 12	bleeding, infection, tendon rupture, allergic reaction, paralysis, or stroke
Activity Level	Week 12	Function, sleep, general well-being, return to normal activities, work, sports and reduction in pain medication usage.

Trial Locations

Locations (2)

Hospital for Special Surgery; 🇺🇸 New York, New York, United States

Department of Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai; 🇺🇸 New York, New York, United States